Latest Retina Stories
TARRYTOWN, N.Y., Jan. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
PARIS, January 7, 2015 /PRNewswire/ -- This public - private project with an overall budget of EUR 47 million aims to restore vision to legally blind patients with
National research foundation awards $1.2 million to scientists conducting groundbreaking research to find a cure for macular degeneration and other retinal diseases CONSHOHOCKEN, Pa., Dec.
FORT COLLINS, Colo., Dec.
TAU researchers develop groundbreaking wireless material capable of sparking neuronal activity in response to light.
an international team of researchers has found that under certain conditions, the retina can sense infrared light
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
National research foundation will host FREE seminars in Naples and Palm Beach Gardens on age-related macular degeneration to provide information on the latest research, treatment and technology for
More Images (4 images) »